Dreyfus David H, Nagasawa Masayuki, Gelfand Erwin W, Ghoda Lucy Y
Division of Basic Sciences, Department of Pediatrics, National Jewish Medical Research Center, Denver, CO 80262 USA.
BMC Immunol. 2005 Jun 21;6:12. doi: 10.1186/1471-2172-6-12.
In this work we present evidence that the p53 tumor suppressor protein and NF-kappaB transcription factors could be related through common descent from a family of ancestral transcription factors regulating cellular proliferation and apoptosis. P53 is a homotetrameric transcription factor known to interact with the ankyrin protein 53BP2 (a fragment of the ASPP2 protein). NF-kappaB is also regulated by ankyrin proteins, the prototype of which is the IkappaB family. The DNA binding sequences of the two transcription factors are similar, sharing 8 out of 10 nucleotides. Interactions between the two proteins, both direct and indirect, have been noted previously and the two proteins play central roles in the control of proliferation and apoptosis.
Using previously published structure data, we noted a significant degree of structural alignment between p53 and NF-kappaB p65. We also determined that IkappaBalpha and p53 bind in vitro through a specific interaction in part involving the DNA binding region of p53, or a region proximal to it, and the amino terminus of IkappaBalpha independently or cooperatively with the ankyrin 3 domain of IkappaBalpha In cotransfection experiments, kappaBalpha could significantly inhibit the transcriptional activity of p53. Inhibition of p53-mediated transcription was increased by deletion of the ankyrin 2, 4, or 5 domains of IkappaBalpha Co-precipitation experiments using the stably transfected ankyrin 5 deletion mutant of kappaBalpha and endogenous wild-type p53 further support the hypothesis that p53 and IkappaBalpha can physically interact in vivo.
The aggregate results obtained using bacterially produced IkappaBalpha and p53 as well as reticulocyte lysate produced proteins suggest a correlation between in vitro co-precipitation in at least one of the systems and in vivo p53 inhibitory activity. These observations argue for a mechanism involving direct binding of IkappaBalpha to p53 in the inhibition of p53 transcriptional activity, analogous to the inhibition of NF-kappaB by kappaBalpha and p53 by 53BP2/ASPP2. These data furthermore suggest a role for ankyrin proteins in the regulation of p53 activity. Taken together, the NFkappaB and p53 proteins share similarities in structure, DNA binding sites and binding and regulation by ankyrin proteins in support of our hypothesis that the two proteins share common descent from an ancestral transcriptional factor.
在本研究中,我们提供证据表明,p53肿瘤抑制蛋白和核因子-κB转录因子可能通过调控细胞增殖和凋亡的祖先转录因子家族的共同起源而相关。p53是一种同四聚体转录因子,已知其与锚蛋白53BP2(ASPP2蛋白的一个片段)相互作用。核因子-κB也受锚蛋白调控,其原型是IκB家族。这两种转录因子的DNA结合序列相似,10个核苷酸中有8个相同。先前已注意到这两种蛋白之间存在直接和间接的相互作用,且它们在增殖和凋亡控制中起核心作用。
利用先前发表的结构数据,我们发现p53与核因子-κB p65之间存在显著程度的结构比对。我们还确定,IκBα与p53在体外通过一种特异性相互作用结合,这种相互作用部分涉及p53的DNA结合区域或其附近区域,以及IκBα的氨基末端,IκBα的锚蛋白3结构域可独立或协同参与该结合。在共转染实验中,IκBα可显著抑制p53的转录活性。删除IκBα的锚蛋白2、4或5结构域可增强对p53介导转录的抑制作用。使用稳定转染的IκBα锚蛋白5缺失突变体和内源性野生型p53进行的共沉淀实验进一步支持了p53与IκBα在体内可发生物理相互作用的假说。
使用细菌产生的IκBα和p53以及网织红细胞裂解物产生的蛋白所获得的总体结果表明,至少在其中一个系统中,体外共沉淀与体内p53抑制活性之间存在相关性。这些观察结果支持了一种机制,即IκBα通过直接结合p53来抑制p53的转录活性,这类似于IκBα对核因子-κB的抑制以及53BP2/ASPP2对p53的抑制。这些数据还表明锚蛋白在p53活性调控中发挥作用。综上所述,核因子-κB和p53蛋白在结构、DNA结合位点以及与锚蛋白的结合和调控方面存在相似性,支持了我们的假说,即这两种蛋白起源于共同的祖先转录因子。